MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

LMB News

Heptares Therapeutics Announces Agreement With Novartis Option Fund

Published on

Heptares Therapeutics Ltd, the drug discovery company focused on G-protein-coupled receptor (GPCR) targets, has recently announced that it has entered into an option agreement with the Novartis Option Fund under which Heptares will apply its proprietary StaR(TM) technology to generate novel drug leads against a nominated, unspecified GPCR target of interest to Novartis. The agreement […]

Dr Venki Ramakrishnan wins 2009 Nobel Prize for Chemistry

Published on

This year’s chemistry Nobel Prize has been awarded to Dr Venki Ramakrishnan of LMB for “studies of the structure and function of the ribosome”. Venki Ramakrishnan shares the honour with Thomas A. Steitz (Yale University) and Ada E. Yonath (Weizmann Institute of Science, Israel). The trio showed how the information encoded on strands of DNA […]

Human Antibodies developed for Treatment of Lupus and Anthrax

Published on

Two therapies with their roots in antibody technology developed in the LMB and the Scripps Research Institute* have recently emerged as promising new drug candidates to treat lupus, a potentially fatal autoimmune disease, and anthrax, a pressing concern due to bioterrorism. The drug candidates—belimumab (BENLYSTATM, formerly LumphoStat-B®), developed by Human Genome Sciences with GlaxoSmithKine as […]